Abstract:Glycosylation is one of the most ubiquitous post‐translational modifications. It affects the structure and function of peptides/proteins and consequently has a significant impact on various biological events. However, the structural complexity and heterogeneity of glycopeptides/proteins caused by the diversity of glycan structures and glycosylation sites complicates the detailed elucidation of glycan function and hampers their clinical applications. To address these challenges, chemical and/or enzyme‐assisted synthesis methods have been developed to realize glycopeptides/proteins with well‐defined glycan morphologies. In particular, N‐glycans are expected to be useful for improving the solubility, in vivo half‐life and aggregation of bioactive peptides/proteins that have had limited clinical applications so far due to their short duration of action in the blood and unsuitable physicochemical properties. Chemical glycosylation performed in a post‐synthetic procedure can be used to facilitate the development of glycopeptide/protein analogues or mimetics that are superior to the original molecules in terms of physicochemical and pharmacokinetic properties. N‐glycans are used to modify targets because they are highly biodegradable and biocompatible and have structures that already exist in the human body. On the practical side, from a quality control perspective, close attention should be paid to their structural homogeneity when they are to be applied to pharmaceuticals.

Improve Stability of Bioactive Peptides by Enzymatic Modular Synthesis of Peptides with O-Linked Sialyl Lewis X

Exploiting Complex-Type N-Glycan to Improve the in Vivo Stability of Bioactive Peptides

Solid-phase guanidyl-formation triggered peptide stapling and cyclization: A robust platform for improving multiple properties of bioactive peptides

Silver-promoted solid-phase guanidyl-formation triggered peptide stapling and cyclization: A robust platform for improving multiple properties of bioactive peptides

Optimizing the Semisynthesis Towards Glycosylated Interferon-Β-polypeptide by Utilizing Bacterial Protein Expression and Chemical Modification.

Greener liquid-phase synthesis and the ACE inhibitory structure-activity relationship of an anti-SARS octapeptide.

Clickable,Oxidation-Responsive and Enzyme-Degradable Polypeptide:Synthesis,Characterization and Side Chain Modification

Methodology of Stable Peptide Based on Propargylated Sulfonium

Chemical and Enzymatic Synthesis of S-linked Sugars and Glycoconjugates

Α/sulfono-Γ-aapeptide Hybrid Analogues of Glucagon with Enhanced Stability and Prolonged in Vivo Activity

Chemical and Chemoenzymatic Synthesis of Peptide and Protein Therapeutics Conjugated with Human N‐Glycans

Stabilization of Peptides Against Proteolysis Through Disulfide-Bridged Conjugation with Synthetic Aromatics.

A chemoenzymatic strategy for site-selective functionalization of native peptides and proteins

Direct Formation of Amide-Linked C-Glycosyl Amino Acids and Peptides via Photoredox/Nickel Dual Catalysis

Peptide Glycosylation Generates Supramolecular Assemblies from Glycopeptides As Biomimetic Scaffolds for Cell Adhesion and Proliferation

Protection-Free Site-Directed Peptide or Protein S -Glycosylation and Its Application in the Glycosylation of Glucagon-like Peptide 1

An Effective Modification Strategy to Build Multifunctional Peptides Based on a Trypsin Inhibitory Peptide of the Kunitz Family

Variant fatty acid-like molecules Conjugation, novel approaches for extending the stability of therapeutic peptides

Non-enzymatic Stereoselective S-glycosylation of Polypeptides and Proteins

Palladium‐Catalyzed Stereospecific S‐Glycosylation by Allylic Substitution

Chemical synthesis and functional evaluation of glycopeptides and glycoproteins containing rare glycosyl amino acid linkages